LGMD2B Now Classified as LGMDR2
1 clinical trials · Condition
◉ Watch LGMD2B Now Classified as LGMDR2
| Record | Firm | Date |
|---|---|---|
| Clinical Outcome Study for Dysferlinopathy (NCT01676077) | Newcastle-upon-Tyne Hospitals NHS Trust | 2012-09-01 |
Track LGMD2B Now Classified as LGMDR2 automatically
Every clearance here is in the API, with alerts when new ones post.